Product Information
QUETIAPINE ER 50 MG TABLET is a generic product labeled by Accord Healthcare Inc., priced at $0.1207 per EA under NDC 16729013212. Its NADAC has been published 451 times since Jan 3, 2018.
FDA first approved this application on Nov 29, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the QUETIAPINE FUMARATE market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
50 mg/1
Manufacturer
Accord Healthcare Inc.NDC
16729013212
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
QUETIAPINE FUMARATEApproval Type
Generic (ANDA)
FDA Application
ANDA206252FDA Approved
11/29/2017
TE Code
AB
On Market Since
11/30/2017
Pharmacological Classes
Price Statistics
The NADAC for QUETIAPINE ER 50 MG TABLET has been published 451 times since Jan 3, 2018, and over the history we have for it it has declined 82.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1207 per EA |
|---|---|
| All-time high | $0.7161 (Mar 14, 2018) |
| All-time low | $0.0912 (Apr 17, 2024) |
| 52-week high | $0.1207 |
| 52-week low | $0.1082 |
| Median price | $0.1724 |
| Average price | $0.2348 |
| Largest weekly change | +44.5% (May 22, 2019) |
| Weeks tracked | 451 |
| Tracking since | Jan 3, 2018 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 9% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of QUETIAPINE ER 50 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for QUETIAPINE ER 50 MG TABLET, manufactured by Accord Healthcare Inc., is $0.1207 per EA (NDC 16729013212), effective Aug 19, 2026.
How has the price of QUETIAPINE ER 50 MG TABLET changed over time?
Over the history we have for it, the NADAC for QUETIAPINE ER 50 MG TABLET has declined 82.8%. It has been tracked across 451 weekly CMS publications since Jan 3, 2018.
What are the highest and lowest recorded NADAC prices for QUETIAPINE ER 50 MG TABLET?
Since Jan 3, 2018, the NADAC for QUETIAPINE ER 50 MG TABLET has ranged from a low of $0.0912 (Apr 17, 2024) to a high of $0.7161 (Mar 14, 2018), with a median of $0.1724 per EA.
Are there cheaper alternatives to QUETIAPINE ER 50 MG TABLET?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, QUETIAPINE ER 50 MG TABLET, is $0.1099 per EA — about 9% below QUETIAPINE ER 50 MG TABLET.
Who manufactures QUETIAPINE ER 50 MG TABLET?
QUETIAPINE ER 50 MG TABLET (NDC 16729013212) is labeled by Accord Healthcare Inc., and CMS classifies it as a generic product.